AHA 2020: STRENGTH Trial Finds No Effect of Omega-3 Carboxylic Acid on Reduction in Cardiovascular Risk
Results cast doubt on the benefit of omega-3s in cardiovascular disease and further supports risk of atrial fibrillation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.